Literature DB >> 11171523

Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations.

Z Smerhovsky1, K Landa, P Rössner, M Brabec, Z Zudova, N Hola, Z Pokorna, J Mareckova, D Hurychova.   

Abstract

We used cytogenetic analysis to carry out a cohort study in which the major objective was to test the association between frequency of chromosomal aberrations and subsequent risk of cancer. In spite of the extensive use of the cytogenetic analysis of human peripheral blood lymphocytes in biomonitoring of exposure to various mutagens and carcinogens on an ecologic level, the long-term effects of an increased frequency of chromosomal aberrations in individuals are still uncertain. Few epidemiologic studies have addressed this issue, and a moderate risk of cancer in individuals with an elevated frequency of chromosomal aberrations has been observed. In the present study, we analyzed data on 8,962 cytogenetic tests and 3,973 subjects. We found a significant and strong association between the frequency of chromosomal aberrations and cancer incidence in a group of miners exposed to radon, where a 1% increase in frequency of chromosomal aberrations was followed by a 64% increase in risk of cancer (p < 0.000). In contrast, the collected data are inadequate for a critical evaluation of the association with exposure to other chemicals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171523      PMCID: PMC1242049          DOI: 10.1289/ehp.0110941

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  17 in total

1.  Monitoring of human exposure to occupational genotoxicants.

Authors:  P Rossner; M Cerna; H Bavorova; A Pastorkova; D Ocadlikova
Journal:  Cent Eur J Public Health       Date:  1995-11       Impact factor: 1.163

2.  Chromosomal abnormalities in soft coal open-cast mining workers.

Authors:  R J Srám; N Holá; F Kotĕsovec; R Vávra
Journal:  Mutat Res       Date:  1985-12       Impact factor: 2.433

3.  Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage.

Authors:  L Hagmar; A Brøgger; I L Hansteen; S Heim; B Högstedt; L Knudsen; B Lambert; K Linnainmaa; F Mitelman; I Nordenson
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

4.  Spontaneous level of chromosomal aberrations in peripheral blood lymphocytes of control individuals of the Czech Republic population.

Authors:  P Rössner; R J Srám; H Bavorová; D Ocadlíková; M Cerná; E Svandová
Journal:  Toxicol Lett       Date:  1998-08       Impact factor: 4.372

5.  Cytogenetic analysis of peripheral blood lymphocytes in glass workers occupationally exposed to mineral oils.

Authors:  R J Srám; N Holá; F Kotĕsovec; A Novákova
Journal:  Mutat Res       Date:  1985-12       Impact factor: 2.433

Review 6.  Human cytogenetic damage as a predictor of cancer risk.

Authors:  M Sorsa; J Wilbourn; H Vainio
Journal:  IARC Sci Publ       Date:  1992

7.  Chromosome aberrations in lymphocytes from women irradiated for benign and malignant gynecological disease.

Authors:  R A Kleinerman; L G Littlefield; R E Tarone; A M Sayer; D L Cookfair; J Wactawski-Wende; P D Inskip; A Block; K H Ramesh; J D Boice
Journal:  Radiat Res       Date:  1994-07       Impact factor: 2.841

8.  Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).

Authors:  L Hagmar; S Bonassi; U Strömberg; A Brøgger; L E Knudsen; H Norppa; C Reuterwall
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

9.  Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study.

Authors:  S Bonassi; A Abbondandolo; L Camurri; L Dal Prá; M De Ferrari; F Degrassi; A Forni; L Lamberti; C Lando; P Padovani
Journal:  Cancer Genet Cytogenet       Date:  1995-02

10.  [Biomarkers of cytogenetic damage in humans and risk of cancer. The European Study Group on Cytogenetic Biomarkers and Health (ESCH)].

Authors:  C Lando; L Hagmar; S Bonassi
Journal:  Med Lav       Date:  1998 Mar-Apr       Impact factor: 1.275

View more
  14 in total

1.  Chromosomal aberrations in peripheral blood lymphocytes and risk for non-Hodgkin lymphoma.

Authors:  Sophia S Wang; Scott Davis; Patricia Hartge; Wendy Cozen; Richard K Severson; James R Cerhan; Nathaniel Rothman
Journal:  J Natl Cancer Inst Monogr       Date:  2008

2.  Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers.

Authors:  Randa A El-Zein; Michael Fenech; Mirtha S Lopez; Margaret R Spitz; Carol J Etzel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-05       Impact factor: 4.254

Review 3.  Applicability of the comet assay in evaluation of DNA damage in healthcare providers' working with antineoplastic drugs: a systematic review and meta-analysis.

Authors:  Mohammad Javad Zare Sakhvidi; Mohammad Hajaghazadeh; Mehrdad Mostaghaci; Amir Houshang Mehrparvar; Fariba Zare Sakhvidi; Elham Naghshineh
Journal:  Int J Occup Environ Health       Date:  2016-04-25

4.  Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.

Authors:  Ruth L Katz; Weigong He; Abha Khanna; Ricardo L Fernandez; Tanweer M Zaidi; Matthew Krebs; Nancy P Caraway; Hua-Zhong Zhang; Feng Jiang; Margaret R Spitz; David P Blowers; Carlos A Jimenez; Reza J Mehran; Stephen G Swisher; Jack A Roth; Jeffrey S Morris; Carol J Etzel; Randa El-Zein
Journal:  Clin Cancer Res       Date:  2010-07-22       Impact factor: 12.531

Review 5.  Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs.

Authors:  Christine Roussel; Kristine L Witt; Peter B Shaw; Thomas H Connor
Journal:  Mutat Res Rev Mutat Res       Date:  2017-08-24       Impact factor: 5.657

Review 6.  Biomarkers of chromosomal damage in peripheral blood lymphocytes induced by polycyclic aromatic hydrocarbons: a meta-analysis.

Authors:  Yadong Wang; Haiyan Yang; Li Li; Haiyu Wang; Xiangqun Xia; Congke Zhang
Journal:  Int Arch Occup Environ Health       Date:  2011-04-02       Impact factor: 3.015

Review 7.  Evaluating the effects of genetic variants of DNA repair genes using cytogenetic mutagen sensitivity approaches.

Authors:  Sherif Z Abdel-Rahman; Randa A El-Zein
Journal:  Biomarkers       Date:  2011-05-20       Impact factor: 2.658

8.  The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.

Authors:  Randa A El-Zein; Mirtha S Lopez; Anthony M D'Amelio; Mei Liu; Reginald F Munden; David Christiani; Li Su; Paula Tejera-Alveraz; Rihong Zhai; Margaret R Spitz; Carol J Etzel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-29       Impact factor: 4.254

9.  Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer.

Authors:  Pavel Rossner; Paolo Boffetta; Marcello Ceppi; Stefano Bonassi; Zdenek Smerhovsky; Karel Landa; Dagmar Juzova; Radim J Srám
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

10.  The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants.

Authors:  Randa A El-Zein; Carol J Etzel; Reginald F Munden
Journal:  Transl Lung Cancer Res       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.